Last reviewed 2026-04-19 · How we verify

YKP10811 Drug Product Capsule

SK Life Science, Inc. · Phase 2 active Small molecule

YKP10811 Drug Product Capsule is a Small molecule drug developed by SK Life Science, Inc.. It is currently in Phase 2 development.

At a glance

Generic name	YKP10811 Drug Product Capsule
Sponsor	SK Life Science, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

YKP10811 Drug Product Capsule CI brief — competitive landscape report
YKP10811 Drug Product Capsule updates RSS · CI watch RSS
SK Life Science, Inc. portfolio CI

Frequently asked questions about YKP10811 Drug Product Capsule

What is YKP10811 Drug Product Capsule?

YKP10811 Drug Product Capsule is a Small molecule drug developed by SK Life Science, Inc..

Who makes YKP10811 Drug Product Capsule?

YKP10811 Drug Product Capsule is developed by SK Life Science, Inc. (see full SK Life Science, Inc. pipeline at /company/sk-life-science-inc).

What development phase is YKP10811 Drug Product Capsule in?

YKP10811 Drug Product Capsule is in Phase 2.

Manufacturer: SK Life Science, Inc. — full pipeline
Compare: YKP10811 Drug Product Capsule vs similar drugs
Pricing: YKP10811 Drug Product Capsule cost, discount & access